Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-14 7:17 pm Purchase | 13G | KIORA PHARMACEUTICALS INC KPRX | Lind Global Fund II LP | 109,160 3.500% | 109,160 (New Position) | View |
2024-11-14 4:45 pm Purchase | 13G | KIORA PHARMACEUTICALS INC KPRX | ADAR1 Capital Management LLC | 315,103 9.990% | 315,103 (New Position) | View |
2024-11-14 4:32 pm Purchase | 13G | KIORA PHARMACEUTICALS INC KPRX | Alyeska Investment Group L.P. | 256,408 8.400% | 256,408 (New Position) | View |
2024-11-13 5:34 pm Purchase | 13G | KIORA PHARMACEUTICALS INC KPRX | Stonepine Capital Management LLC | 307,229 9.990% | 307,229 (New Position) | View |
2024-11-12 5:58 pm Purchase | 13G | KIORA PHARMACEUTICALS INC KPRX | GOLDMAN SACHS GROUP INC GS | 180,792 6.100% | 180,792 (New Position) | View |
2024-05-29 3:47 pm Unchanged | 13G | KIORA PHARMACEUTICALS INC KPRX | Rosalind Advisors Inc. | 4,182,094 9.900% | 0 (Unchanged) | View |
2024-05-29 3:43 pm Purchase | 13G | KIORA PHARMACEUTICALS INC KPRX | Rosalind Advisors Inc. | 4,182,094 9.900% | 4,182,094 (New Position) | View |
2024-02-14 4:55 pm Sale | 13G | KIORA PHARMACEUTICALS INC KPRX | Lincoln Park Capital Fund LLC | 2,346,575 9.990% | -933,901 (-28.47%) | View |
2024-02-13 8:08 pm Purchase | 13G | KIORA PHARMACEUTICALS INC KPRX | Lind Global Fund II LP | 845,000 9.900% | 499,490 (+144.57%) | View |
2024-02-09 4:16 pm Purchase | 13G | KIORA PHARMACEUTICALS INC KPRX | Stonepine Capital Management LLC | 2,409,058 9.990% | 2,409,058 (New Position) | View |
2024-02-07 09:22 am Purchase | 13G | KIORA PHARMACEUTICALS INC KPRX | HIRSCHMAN ORIN | 2,300,000 9.900% | 2,300,000 (New Position) | View |
2024-02-06 10:27 am Sale | 13G | KIORA PHARMACEUTICALS INC KPRX | INTRACOASTAL CAPITAL LLC | 117,108 1.500% | -55,663 (-32.22%) | View |
2023-06-13 4:02 pm Purchase | 13G | KIORA PHARMACEUTICALS INC KPRX | Lind Global Fund II LP | 345,510 9.900% | 192,440 (+125.72%) | View |
2023-02-14 1:01 pm Purchase | 13G | KIORA PHARMACEUTICALS INC KPRX | ARMISTICE CAPITAL LLC | 89,997 4.770% | 89,997 (New Position) | View |
2023-02-13 4:38 pm Purchase | 13G | KIORA PHARMACEUTICALS INC KPRX | Lind Global Fund II LP | 153,070 7.900% | 153,070 (New Position) | View |
2023-02-13 4:37 pm Unchanged | 13G | KIORA PHARMACEUTICALS INC KPRX | Lind Global Macro Fund LP | 0 0.000% | 0 (Unchanged) | View |
2023-02-08 06:07 am Purchase | 13G | KIORA PHARMACEUTICALS INC KPRX | INTRACOASTAL CAPITAL LLC | 172,771 9.000% | 172,771 (New Position) | View |
2022-08-05 5:23 pm Purchase | 13G | KIORA PHARMACEUTICALS INC KPRX | Lind Global Fund II LP | 3,666,750 9.900% | 3,232,439 (+744.27%) | View |
2022-08-01 06:06 am Purchase | 13G | KIORA PHARMACEUTICALS INC KPRX | INTRACOASTAL CAPITAL LLC | 3,467,774 9.990% | 3,467,774 (New Position) | View |
2022-07-28 5:09 pm Purchase | 13G | KIORA PHARMACEUTICALS INC KPRX | Lincoln Park Capital Fund LLC | 3,280,476 9.990% | 3,280,476 (New Position) | View |